| Drug Type Small molecule drug | 
| Synonyms- | 
| Action modulators | 
| Mechanism HDAC1 modulators(Histone deacetylase 1 modulators), HDAC10 modulators(Histone deacetylase 10 modulators), HDAC2 modulators(Histone deacetylase 2 modulators) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Ovarian Epithelial Carcinoma | Preclinical | - | 19 Dec 2022 | 





